The device giant temporarily recalled the device for a month to investigate potential causes for high revision rates. The company later found the high revision rates were due to improper implantation techniques and returned the device to the market.
Since then, Zimmer has been subject to legal action connected to the Durom device. So far, it has doled more than $98 million for Durom-related claim and expects to pay approximately $290 million more.
More Articles on Orthopedic Devices:
DePuy Launches New Trumatch Pin for Orthopedic Implants
Investors Increase Stake in Smith & Nephew
Titan Spine Appoints Marcus Klarl Vice President of Sales
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.